2010
This collaborative project will identify and characterize novel curcumin-like derivatives for the treatment and prevention of Alzheimer’s disease. The purpose of the study is to develop means of overcoming obstacles to rapid breakdown and creating methodologies for precisely delivering curcumin derivatives to appropriate locations within the brain.
$400,000
Drug Discovery, Drug Screening Projects
Rudolph Tanzi, Ph.D.
William Klunk, M.D., Ph.D.